Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G EVANS

Showing results (351-360 of 392) with videos related to

Pageof 40
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testingC F Rowlands, S Allen, J Balmaña, et al.
British Journal of Cancer|February 16, 2012
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 yearsL Robertson, H Hanson, S Seal, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 18, 2020
Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort studyF Gaba, O Blyuss, D Chandrasekaran, et al.
Journal of Medical Genetics|April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersD G Evans, K N Gaarenstroom, D Stirling, et al.
Journal of Medical Genetics|September 9, 2000
Recurrent germline mutation in MSH2 arises frequently de novoD C Desai, J C Lockman, R B Chadwick, et al.
Disease Markers|December 14, 1999
Insurance implications for individuals with a high risk of breast and ovarian cancer in EuropeP J Morrison, C M Steel, H F Vasen, et al.
Neurology|June 16, 2005
Diagnostic criteria for schwannomatosisM MacCollin, E A Chiocca, D G Evans, et al.
Ebiomedicine|June 21, 2016
Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features OnlyD G Evans, N Bowers, E Burkitt-Wright, et al.
Eclinicalmedicine|April 23, 2019
Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast CancerD G Evans, S Thomas, J Caunt, et al.
Journal of Neuro-Oncology|December 1, 2017
Spinal ependymomas in NF2: a surgical disease?M Kalamarides, W Essayed, J P Lejeune, et al.
Pageof 40

Showing results (351-360 of 392) with videos related to

Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testingC F Rowlands, S Allen, J Balmaña, et al.
British Journal of Cancer|February 16, 2012
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 yearsL Robertson, H Hanson, S Seal, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 18, 2020
Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort studyF Gaba, O Blyuss, D Chandrasekaran, et al.
Journal of Medical Genetics|April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersD G Evans, K N Gaarenstroom, D Stirling, et al.
Journal of Medical Genetics|September 9, 2000
Recurrent germline mutation in MSH2 arises frequently de novoD C Desai, J C Lockman, R B Chadwick, et al.
Disease Markers|December 14, 1999
Insurance implications for individuals with a high risk of breast and ovarian cancer in EuropeP J Morrison, C M Steel, H F Vasen, et al.
Neurology|June 16, 2005
Diagnostic criteria for schwannomatosisM MacCollin, E A Chiocca, D G Evans, et al.
Ebiomedicine|June 21, 2016
Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features OnlyD G Evans, N Bowers, E Burkitt-Wright, et al.
Eclinicalmedicine|April 23, 2019
Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast CancerD G Evans, S Thomas, J Caunt, et al.
Journal of Neuro-Oncology|December 1, 2017
Spinal ependymomas in NF2: a surgical disease?M Kalamarides, W Essayed, J P Lejeune, et al.
Pageof 40